Primer: first do no harm--when is it appropriate to plan a cancer prevention clinical trial?
about
Cancer and inflammation: promise for biologic therapy.Impact of Short-term 1,25-Dihydroxyvitamin D3 on the Chemopreventive Efficacy of Erlotinib against Oral Cancer.Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines
P2860
Primer: first do no harm--when is it appropriate to plan a cancer prevention clinical trial?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Primer: first do no harm--when ...... cer prevention clinical trial?
@en
Primer: first do no harm--when ...... cer prevention clinical trial?
@nl
type
label
Primer: first do no harm--when ...... cer prevention clinical trial?
@en
Primer: first do no harm--when ...... cer prevention clinical trial?
@nl
prefLabel
Primer: first do no harm--when ...... cer prevention clinical trial?
@en
Primer: first do no harm--when ...... cer prevention clinical trial?
@nl
P2860
P356
P1476
Primer: first do no harm--when ...... cer prevention clinical trial?
@en
P2093
P2860
P304
P356
10.1038/NCPONC1123
P50
P577
2008-04-29T00:00:00Z